Kaneh Bosm BioTechnology Inc. is a listed company. Its insiders report their share dealings to SEDI. Kaneh Bosm BioTechnology Inc. has had no insider filing for more than a year; the last one goes back to 1 May 2018.
Over the whole record (from 2017), the tally stands at no purchases and 15 sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 25 declarations
Kaneh Bosm BioTechnology Inc. is a Canadian company focused on developing cannabis-based products. It is listed on the Toronto Stock Exchange under the symbol XTSE.